Michal Mikula

Prof. Michal Mikula

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMagdalena Skrzypczak
Magdalena Skrzypczak
KGKrzysztof Goryca
Krzysztof Goryca
TRTymon Rubel
Tymon Rubel
APAgnieszka Paziewska
Agnieszka Paziewska
MMMichal Mikula
Michal Mikula
JOJerzy Ostrowski
Jerzy Ostrowski
Clinical progression of colorectal cancers (CRC) may occur in parallel with distinctive signaling alterations. We designed multidirectional analyses integrating microarray-based data with biostatistics and bioinformatics to elucidate the signaling and metabolic alterations underlying CRC development in the adenoma-carcinoma sequence. Studies were performed on normal mucosa, adenoma, and carcinoma samples obtained during surgery or colonoscopy. Collections of cryostat sections prepared from the tissue samples were evaluated by a pathologist to control the relative cell type content. The measurements were done using Affymetrix GeneChip HG-U133plus2, and probe set data was generated using two normalization algorithms: MAS5.0 and GCRMA with least-variant set (LVS). The data was evaluated using pair-wise comparisons and data decomposition into singular value decomposition (SVD) modes. The method selected for the functional analysis used the Kolmogorov-Smirnov test. Expressional profiles obtained in 105 samples of whole tissue sections were used to establish oncogenic signaling alterations in progression of CRC, while those representing 40 microdissected specimens were used to select differences in KEGG pathways between epithelium and mucosa. Based on a consensus of the results obtained by two normalization algorithms, and two probe set sorting criteria, we identified 14 and 17 KEGG signaling and metabolic pathways that are significantly altered between normal and tumor samples and between benign and malignant tumors, respectively. Several of them were also selected from the raw microarray data of 2 recently published studies (GSE4183 and GSE8671). Although the proposed strategy is computationally complex and labor–intensive, it may reduce the number of false results.

29 March 2012 in Genome Biology
Verified
Journal Article
Open access
PDF file
DYDimas Yusuf
Dimas Yusuf
SBStefanie L Butland
Stefanie L Butland
MSMagdalena I Swanson
Magdalena I Swanson
EBEugene Bolotin
Eugene Bolotin
ATAmy Ticoll
Amy Ticoll
WWWyeth W Wasserman
Wyeth W Wasserman
Here we present the Transcription Factor Encyclopedia (TFe), a new web-based compendium of mini review articles on transcription factors (TFs) that is founded on the principles of open access and collaboration. Our consortium of over 100 researchers has collectively contributed over 130 mini review articles on pertinent human, mouse and rat TFs. Notable features of the TFe website include a high-quality PDF generator and web API for programmatic data retrieval. TFe aims to rapidly educate scientists about the TFs they encounter through the delivery of succinct summaries written and vetted by experts in the field. TFe is available at http://www.cisreg.ca/tfe.

9 November 2010 in Functional & Integrative Genomics
Verified
Journal Article
Closed access
PDF file
MMMichal Mikula
Michal Mikula
TRTymon Rubel
Tymon Rubel
JKJakub Karczmarski
Jakub Karczmarski
KGKrzysztof Goryca
Krzysztof Goryca
MDMichal Dadlez
Michal Dadlez
JOJerzy Ostrowski
Jerzy Ostrowski

4 April 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
TRTomasz Rzymski
Tomasz Rzymski
MMMichal Mikula
Michal Mikula
EŻEliza Żyłkiewicz
Eliza Żyłkiewicz
ADAgnieszka Dreas
Agnieszka Dreas
KWKatarzyna Wiklik
Katarzyna Wiklik
KBKrzysztof Brzózka
Krzysztof Brzózka
SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains

13 May 2020 in Gut Microbes
Verified
Journal Article
Open access
MKMaria Kulecka
Maria Kulecka
BFBarbara Frączek
Barbara Frączek
MMMichal Mikula
Michal Mikula
NZNatalia Zeber-Lubecka
Natalia Zeber-Lubecka
JKJakub Karczmarski
Jakub Karczmarski
JOJerzy Ostrowski
Jerzy Ostrowski
Little data are available on the subject of gut microbiota composition in endurance athletes as well as connections between diet and specific bacteria abundance. However, most studies suggest that ...

3 June 2014 in Clinical Proteomics
Verified
Journal Article
Open access
PDF file
JKJakub Karczmarski
Jakub Karczmarski
TRTymon Rubel
Tymon Rubel
APAgnieszka Paziewska
Agnieszka Paziewska
MMMichal Mikula
Michal Mikula
MBMateusz Bujko
Mateusz Bujko
JOJerzy Ostrowski
Jerzy Ostrowski
Histone post-translational modifications (PTMs) play an important role in the regulation of the expression of genes, including those involved in cancer development and progression. However, our knowledge of PTM patterns in human tumours is limited.